Comparison between Indegene IPO and Kronox Lab Sciences IPO.
Indegene IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Kronox Lab Sciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Indegene IPO is up to ₹1,841.76 Cr whereas the issue size of the Kronox Lab Sciences IPO is up to ₹130.15 Cr. The final issue price of Indegene IPO is ₹452.00 per share and of Kronox Lab Sciences IPO is ₹136.00 per share.
| Indegene IPO | Kronox Lab Sciences IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹430.00 per share | ₹129.00 per share |
| Issue Price (Upper) | ₹452.00 per share | ₹136.00 per share |
| Issue Price (Final) | ₹452.00 per share | ₹136.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹30.00 per share | |
| Market Lot Size | 33 shares | 110 shares |
| Fresh Issue Size | 1,68,33,818 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹760.52 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 2,39,32,732 shares | 95,70,000 shares |
| OFS Issue Size (Amount) | up to ₹1,081.24 Cr | up to ₹130.15 Cr |
| Issue Size Total | 4,07,66,550 shares | 95,70,000 shares |
| Issue Size Total (Amount) | up to ₹1,841.76 Cr | up to ₹130.15 Cr |
Indegene IPO opens on May 06, 2024, while Kronox Lab Sciences IPO opens on Jun 03, 2024. The closing date of Indegene IPO and Kronox Lab Sciences IPO is May 08, 2024, and Jun 05, 2024, respectively.
| Indegene IPO | Kronox Lab Sciences IPO | |
|---|---|---|
| Anchor Bid Date | May 03, 2024 | May 31, 2024 |
| Issue Open | May 06, 2024 | Jun 03, 2024 |
| Issue Close | May 08, 2024 | Jun 05, 2024 |
| Basis Of Allotment (Tentative) | May 09, 2024 | Jun 06, 2024 |
| Initiation of Refunds (Tentative) | May 10, 2024 | Jun 07, 2024 |
| Credit of Share (Tentative) | May 10, 2024 | Jun 07, 2024 |
| Listing date (Tentative) | May 13, 2024 | Jun 10, 2024 |
| Anchor Lockin End date 1 | Jun 08, 2024 | Jul 06, 2024 |
| Anchor Lockin End date 2 | Aug 07, 2024 | Sep 04, 2024 |
Indegene IPO P/E ratio is 37.78, as compared to Kronox Lab Sciences IPO P/E ratio of 30.37.
| Indegene IPO | Kronox Lab Sciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 30.71 | 99.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 37.78 | 30.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹10814.07 Cr. | ₹504.61 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 25.66% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 33.15% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.30 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹11.96 | ₹4.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 18.23% | 25.66% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Indegene IPO Retail Individual Investors (RII) are offered 1,41,64,620 shares while in Kronox Lab Sciences IPO retail investors are offered 1,41,64,620 shares. Qualified Institutional Buyers (QIB) are offered 80,94,068 shares in Indegene IPO and 19,14,000 shares in Kronox Lab Sciences IPO.
| Indegene IPO | Kronox Lab Sciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,21,41,102 shares | 28,71,000 shares |
| Market Maker Reservation | ||
| QIB | 80,94,068 shares | 19,14,000 shares |
| NII | 60,70,552 shares | 14,35,500 shares |
| RII | 1,41,64,620 shares | 33,49,500 shares |
| Employee | 2,96,208 shares | |
| Others | ||
| Total | 4,07,66,550 shares | 95,70,000 shares |
Indegene IPO subscribed 70.30x in total, whereas Kronox Lab Sciences IPO subscribed 117.25x.
| Indegene IPO | Kronox Lab Sciences IPO | |
|---|---|---|
| QIB (times) | 192.72x | 89.03x |
| NII (times) | 55.91x | 301.92x |
| Big NII (times) | 62.23x | 322.26x |
| Small NII (times) | 43.26x | 261.22x |
| RII (times) | 7.86x | 54.24x |
| Employee (times) | 6.62x | |
| Other (times) | ||
| Total (times) | 70.30x | 117.25x |
